PortfoliosLab logo
BAYRY vs. PFE
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between BAYRY and PFE is 0.44, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


Performance

BAYRY vs. PFE - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Bayer AG PK (BAYRY) and Pfizer Inc. (PFE). The values are adjusted to include any dividend payments, if applicable.

Loading data...

Key characteristics

Sharpe Ratio

BAYRY:

-0.17

PFE:

-0.46

Sortino Ratio

BAYRY:

0.07

PFE:

-0.52

Omega Ratio

BAYRY:

1.01

PFE:

0.94

Calmar Ratio

BAYRY:

-0.07

PFE:

-0.19

Martin Ratio

BAYRY:

-0.24

PFE:

-0.80

Ulcer Index

BAYRY:

24.79%

PFE:

14.30%

Daily Std Dev

BAYRY:

40.32%

PFE:

24.17%

Max Drawdown

BAYRY:

-82.45%

PFE:

-58.96%

Current Drawdown

BAYRY:

-74.48%

PFE:

-54.50%

Fundamentals

Market Cap

BAYRY:

$27.74B

PFE:

$133.32B

EPS

BAYRY:

-$0.94

PFE:

$1.38

PEG Ratio

BAYRY:

37.01

PFE:

0.59

PS Ratio

BAYRY:

0.60

PFE:

2.13

PB Ratio

BAYRY:

0.75

PFE:

1.48

Total Revenue (TTM)

BAYRY:

$46.58B

PFE:

$62.46B

Gross Profit (TTM)

BAYRY:

$25.15B

PFE:

$42.09B

EBITDA (TTM)

BAYRY:

$4.49B

PFE:

$16.71B

Returns By Period

In the year-to-date period, BAYRY achieves a 42.08% return, which is significantly higher than PFE's -8.28% return. Over the past 10 years, BAYRY has underperformed PFE with an annualized return of -12.23%, while PFE has yielded a comparatively higher 0.81% annualized return.


BAYRY

YTD

42.08%

1M

7.28%

6M

38.77%

1Y

-6.58%

3Y*

-25.35%

5Y*

-13.96%

10Y*

-12.23%

PFE

YTD

-8.28%

1M

-1.93%

6M

-7.16%

1Y

-11.13%

3Y*

-19.73%

5Y*

-4.00%

10Y*

0.81%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Bayer AG PK

Pfizer Inc.

Go deeper with the Portfolio Analysis tool — backtest performance, assess risk, compare to benchmarks, and more

Risk-Adjusted Performance

BAYRY vs. PFE — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

BAYRY
The Risk-Adjusted Performance Rank of BAYRY is 4141
Overall Rank
The Sharpe Ratio Rank of BAYRY is 4141
Sharpe Ratio Rank
The Sortino Ratio Rank of BAYRY is 3838
Sortino Ratio Rank
The Omega Ratio Rank of BAYRY is 3737
Omega Ratio Rank
The Calmar Ratio Rank of BAYRY is 4646
Calmar Ratio Rank
The Martin Ratio Rank of BAYRY is 4545
Martin Ratio Rank

PFE
The Risk-Adjusted Performance Rank of PFE is 2828
Overall Rank
The Sharpe Ratio Rank of PFE is 2424
Sharpe Ratio Rank
The Sortino Ratio Rank of PFE is 2121
Sortino Ratio Rank
The Omega Ratio Rank of PFE is 2323
Omega Ratio Rank
The Calmar Ratio Rank of PFE is 3838
Calmar Ratio Rank
The Martin Ratio Rank of PFE is 3232
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

BAYRY vs. PFE - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Bayer AG PK (BAYRY) and Pfizer Inc. (PFE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The current BAYRY Sharpe Ratio is -0.17, which is higher than the PFE Sharpe Ratio of -0.46. The chart below compares the historical Sharpe Ratios of BAYRY and PFE, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading data...

Go to the full Sharpe Ratio tool to analyze any stock or portfolio. Customize time frames, set your own risk-free rate, and more

Dividends

BAYRY vs. PFE - Dividend Comparison

BAYRY's dividend yield for the trailing twelve months is around 0.44%, less than PFE's 7.24% yield.


TTM20242023202220212020201920182017201620152014
BAYRY
Bayer AG PK
0.44%0.60%6.81%4.26%4.45%5.22%3.86%7.10%2.33%2.74%10.30%2.14%
PFE
Pfizer Inc.
7.24%6.33%5.70%3.12%2.64%3.92%3.68%3.12%3.53%3.69%3.47%3.34%

Drawdowns

BAYRY vs. PFE - Drawdown Comparison

The maximum BAYRY drawdown since its inception was -82.45%, which is greater than PFE's maximum drawdown of -58.96%. Use the drawdown chart below to compare losses from any high point for BAYRY and PFE.


Loading data...

Go to the full Drawdowns tool for more analysis options, including inflation-adjusted drawdowns, and more

Volatility

BAYRY vs. PFE - Volatility Comparison

Bayer AG PK (BAYRY) has a higher volatility of 13.98% compared to Pfizer Inc. (PFE) at 9.18%. This indicates that BAYRY's price experiences larger fluctuations and is considered to be riskier than PFE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading data...

Financials

BAYRY vs. PFE - Financials Comparison

This section allows you to compare key financial metrics between Bayer AG PK and Pfizer Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


10.00B15.00B20.00B25.00B20212022202320242025
13.74B
13.72B
(BAYRY) Total Revenue
(PFE) Total Revenue
Values in USD except per share items

BAYRY vs. PFE - Profitability Comparison

The chart below illustrates the profitability comparison between Bayer AG PK and Pfizer Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

20.0%30.0%40.0%50.0%60.0%70.0%80.0%20212022202320242025
59.1%
79.3%
(BAYRY) Gross Margin
(PFE) Gross Margin
BAYRY - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Bayer AG PK reported a gross profit of 8.11B and revenue of 13.74B. Therefore, the gross margin over that period was 59.1%.

PFE - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Pfizer Inc. reported a gross profit of 10.87B and revenue of 13.72B. Therefore, the gross margin over that period was 79.3%.

BAYRY - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Bayer AG PK reported an operating income of 2.32B and revenue of 13.74B, resulting in an operating margin of 16.9%.

PFE - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Pfizer Inc. reported an operating income of 2.79B and revenue of 13.72B, resulting in an operating margin of 20.3%.

BAYRY - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Bayer AG PK reported a net income of 1.30B and revenue of 13.74B, resulting in a net margin of 9.5%.

PFE - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Pfizer Inc. reported a net income of 2.97B and revenue of 13.72B, resulting in a net margin of 21.6%.